Exercise in the Management of MAFLD Webinar

Exercise in the Management of MAFLD Webinar

Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults Webinar

A Position Statement from Exercise and Sport Science Australia

Metabolic-associated fatty liver disease (MAFLD, formerly known as non-alcoholic fatty liver disease/NAFLD) affects up to one third of Australians (recent estimate are as high as 39%!) and is becoming more prevalent with the global escalation of obesity-related chronic disease. In addition to increasing risk of end-stage liver disease and liver cancer, MAFLD plays a central role in the development and worsening of type 2 diabetes, cardiovascular disease and extrahepatic cancers. Given the lack of approved pharmaceutical agents, lifestyle therapy is the cornerstone of management for all people with MAFLD. It is now established that exercise is an effective therapy for reducing liver fat, even in the absence of weight loss. 
Exercise professionals play a central role in the multidisciplinary integrated approach to MAFLD management. This webinar will showcase the key recommendations and clinical implications reported in the recently published ESSA Position Statement. In addition to highlighting principals of prescription (and the underlying evidence), the PD will examine the key considerations for implementation of the guidelines.  
Prescriptive targets, outcome testing and evaluation, and special considerations will be discussed for practitioners working in clinical practice. Additionally, insights from people living with MAFLD will be explored giving a unique insight into challenges and opportunities for exercise care in people with MAFLD. 

Presented by Dr Shelley Keating, AES, AEP

Dr Shelley Keating is an Accredited Exercise Physiologist and Senior Lecturer in Clinical Exercise Physiology at the School of Human Movement and Nutrition Sciences, The University of Queensland.  Shelley leads a program of research centred on developing, delivering, and disseminating exercise interventions to manage cardiometabolic risk in adults with metabolic-associated fatty liver disease (MAFLD) and other obesity-related conditions. Her contribution to the field was recognised by the prestigious 2020 Australia and New Zealand Obesity Society Young Investigator award. Shelley has been an ESSA member since 2007 and has 16 years of clinical AEP experience in people with cardiometabolic disease including MAFLD.


Friday, 8 March 2024
1:00pm - 2:30pm AEDT

Please note, the times listed are in Australian Eastern Daylight Time. 
Your local time will be: 
 ACT:          1:00pm - 2:30pm
 NSW:    1:00pm - 2:30pm
 NT:    11:30pm - 1:00pm
 QLD:    12:00pm - 1:30pm
 SA:    12:30pm - 2:00pm
 TAS:    1:00pm - 2:30pm
 VIC:    1:00pm - 2:30pm
 WA:    10:00am - 11:30am
Please note: This is a live webinar and needs to be watched at the specified time above. If you are unable to watch the webinar live, it will be produced as an online activity and can be purchased within the following month.

Rates per person

ESSA Member   $33.00 
Non-Member       $55.00
ESSA Student Member            $16.50
Student Non-Member    $27.50 
ESSA Member PD+   $29.70
Non-Member PD+   $49.50
Please see terms & conditions for registration type definitions.

Access to Webinar

You will be emailed a link to access the webinar approximately one hour prior to the scheduled start time.

Target Audience

Any Accredited Exercise Physiologist



Online: After signing into your ESSA profile, select the blue "Register Now" button 
Manual Form: click here

Registration for this professional development will close at 11:00am AEDT, Friday, 8 March 2024.

Please note:
* Credit card payment is required with online registration.
* If a tax invoice is required for payment to be made, please use the manual form.
* Upon registering to any ESSA professional development, you automatically agree to our terms & conditions.


  • All accredited persons, regardless of any professional development completed/ attended must refer to their accreditation’s Scope of Practice/Standards, and only treat/practice within the same.  
  • ESSA confirms that at the date of release, this professional development meets the requirements of the ESSA Continuing Professional Development Points Guidelines. The information contained in this professional development is of a general nature only, and while every effort and care has been taken to ensure that all representations are accurate as at the date of its release, ESSA accepts no legal liability for any loss or damage suffered as a result of any information provided in this professional development. 
  • ESSA recommends that its members seek appropriate independent professional advice specific to their particular purposes and circumstances (including the provision of medical advice to patients) before relying on it. 
  • All Professional Development logistics are correct at time of publication. Subject to change at anytime without notice.
  • _